Importantly, the ratio of CD274-L2A to variant 1 was generally increased in cancer, as exemplified when comparing healthy lung to lung squamous cell carcinoma (LUSC) or lung adenocarcinoma (LUAD) (Figure 3A). This evidence concerns the gene CD274 and cancer.